1. Monfrini, Edoardo, Spagnolo, Francesca, Canesi, Margherita, Pezzoli, Gianni, Di Fonzo, Alessio. 2021. VPS13C-associated Parkinson's disease: Two novel cases and review of the literature. In Parkinsonism & related disorders, 94, 37-39. doi:10.1016/j.parkreldis.2021.11.031. https://pubmed.ncbi.nlm.nih.gov/34875562/
2. Tan, Xiangyu, Wang, Xueqian, Liao, Xueyao, Hu, Zheng, Tian, Xun. 2023. Downregulation of VPS13C promotes cisplatin resistance in cervical cancer by upregulating GSTP1. In iScience, 26, 107315. doi:10.1016/j.isci.2023.107315. https://pubmed.ncbi.nlm.nih.gov/37520723/
3. Wang, Xinbo, Xu, Peng, Bentley-DeSousa, Amanda, Ferguson, Shawn M, De Camilli, Pietro. 2024. Lysosome damage triggers acute formation of ER to lysosomes membrane tethers mediated by the bridge-like lipid transport protein VPS13C. In bioRxiv : the preprint server for biology, , . doi:10.1101/2024.06.08.598070. https://pubmed.ncbi.nlm.nih.gov/38895395/
4. Ebaid, Amany M, Zakaria, Mohammad A, Mekkawy, Enas M, Shabana, Marwa A, Esawy, Marwa M. 2024. VPS13C and STING expression in neuropsychiatric systemic lupus erythematosus: unveiling an unbreached territory. In Lupus science & medicine, 11, . doi:10.1136/lupus-2024-001271. https://pubmed.ncbi.nlm.nih.gov/39306342/
5. Mehta, Zenobia B, Fine, Nicholas, Pullen, Timothy J, Marchetti, Piero, Rutter, Guy A. 2016. Changes in the expression of the type 2 diabetes-associated gene VPS13C in the β-cell are associated with glucose intolerance in humans and mice. In American journal of physiology. Endocrinology and metabolism, 311, E488-507. doi:10.1152/ajpendo.00074.2016. https://pubmed.ncbi.nlm.nih.gov/27329800/
6. Bai, Xinling, Liu, Xian, Li, Xiaoyuan, Li, Wenjian, Xie, Anmu. 2021. Association between VPS13C rs2414739 polymorphism and Parkinson's disease risk: A meta-analysis. In Neuroscience letters, 754, 135879. doi:10.1016/j.neulet.2021.135879. https://pubmed.ncbi.nlm.nih.gov/33838259/
智鼠故事 
